39 related articles for article (PubMed ID: 15588717)
1. Receptor activator of NF-kappaB ligand induces the fusion of mononuclear preosteoclasts into multinucleated osteoclasts.
Woo JT; Kato M; Takami M; Nagai K
Cytotechnology; 2000 Jul; 33(1-3):203-11. PubMed ID: 19002827
[TBL] [Abstract][Full Text] [Related]
2. Mononuclear phagocyte morphologic response to chemoattractants is dependent on geranylgeranyl pyrophosphate.
Krauklis SA; Hussain J; Murphy KM; Dray EL; Ousley CG; Justyna K; Distefano MD; Steelman AJ; McKim DB
Am J Physiol Endocrinol Metab; 2024 May; ():. PubMed ID: 38717364
[TBL] [Abstract][Full Text] [Related]
3. Development of an image-based screening system for inhibitors of the plastidial MEP pathway and of protein geranylgeranylation.
Hartmann M; Gas-Pascual E; Hemmerlin A; Rohmer M; Bach TJ
F1000Res; 2015; 4():14. PubMed ID: 26309725
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Small GTPase Prenylation in the Nervous System.
Reddy JM; Raut NGR; Seifert JL; Hynds DL
Mol Neurobiol; 2020 May; 57(5):2220-2231. PubMed ID: 31989383
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells' osteogenic differentiation.
Tai IC; Wang YH; Chen CH; Chuang SC; Chang JK; Ho ML
Int J Nanomedicine; 2015; 10():5881-94. PubMed ID: 26451103
[TBL] [Abstract][Full Text] [Related]
6. Approaches of targeting Rho GTPases in cancer drug discovery.
Lin Y; Zheng Y
Expert Opin Drug Discov; 2015; 10(9):991-1010. PubMed ID: 26087073
[TBL] [Abstract][Full Text] [Related]
7. Validity of SW982 synovial cell line for studying the drugs against rheumatoid arthritis in fluvastatin-induced apoptosis signaling model.
Chang JH; Lee KJ; Kim SK; Yoo DH; Kang TY
Indian J Med Res; 2014 Jan; 139(1):117-24. PubMed ID: 24604047
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin release from polycaprolactone coated β-tricalcium phosphate: effects of pH, concentration and drug-polymer interactions.
Tarafder S; Nansen K; Bose S
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3121-8. PubMed ID: 23706191
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
[TBL] [Abstract][Full Text] [Related]
10. Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasis.
Dasgupta S; Cushman I; Kpetemey M; Casey PJ; Vishwanatha JK
J Biol Chem; 2011 Jul; 286(29):25935-46. PubMed ID: 21628459
[TBL] [Abstract][Full Text] [Related]
11. Characterization of dystrophic calcification induced in mice by cardiotoxin.
Zhao Y; Urganus AL; Spevak L; Shrestha S; Doty SB; Boskey AL; Pachman LM
Calcif Tissue Int; 2009 Sep; 85(3):267-75. PubMed ID: 19690791
[TBL] [Abstract][Full Text] [Related]
12. In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I.
Lu J; Chan L; Fiji HD; Dahl R; Kwon O; Tamanoi F
Mol Cancer Ther; 2009 May; 8(5):1218-26. PubMed ID: 19417142
[TBL] [Abstract][Full Text] [Related]
13. Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.
Subramanian T; Liu S; Troutman JM; Andres DA; Spielmann HP
Chembiochem; 2008 Nov; 9(17):2872-82. PubMed ID: 18985644
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).
Woo JT; Nakagawa H; Krecic AM; Nagai K; Hamilton AD; Sebti SM; Stern PH
Biochem Pharmacol; 2005 Jan; 69(1):87-95. PubMed ID: 15588717
[TBL] [Abstract][Full Text] [Related]
15. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
[TBL] [Abstract][Full Text] [Related]
16. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures.
Kaji H; Kanatani M; Sugimoto T; Chihara K
Horm Metab Res; 2005 Oct; 37(10):589-92. PubMed ID: 16278780
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
18. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
Takahashi N
Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the differentiation and function of osteoclasts.
Chambers TJ
J Pathol; 2000 Sep; 192(1):4-13. PubMed ID: 10951393
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
